Sickle cell anemia (HbSS) is the homozygous dominant variant and the most common and severe form of the disease. Whereas patients who only inherited one gene encoding for abnormal HbS and a different ...
Recent therapies like hydroxyurea (Droxia, Bristol-Myers Squibb), the first FDA-approved drug for SCD in 1994, increase fetal hemoglobin (HbF), which, through unknown pathways, improves SCD symptoms ...
The FDA has awarded breakthrough device designation to Hemex Health’s rapid diagnostic test for sickle cell disease and beta ...
Private healthcare provider AAR Hospital on Thursday announced a significant subsidy on critical sickle cell screening tests and free preventative medication, marking World Sickle Cell Day with an ...
SHREVEPORT, La. (KTAL/KMSS) – Two cell-based gene therapies for treating sickle cell disease have been approved by the U.S. Food and Drug Administration, but the treatments are unaffordable for most ...
Sickle cell anemia is a rare blood disorder passed down in families. Doctors can test for the trait that causes it before, during, or soon after birth. Sickle cell anemia (SCA) is an inherited blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results